EP Patent

EP0263213A1 — C20 Through C26 amino steroids

Assigned to Pharmacia and Upjohn Co · Expires 1988-04-13 · 38y expired

What this patent protects

Disclosed are Δ 9(11) -steroids (VI) and amino substituted steroids of formula (XI) which contain an amino group attached to the terminal carbon atom of the C 17 -side chain, more particularly amino steroids (la and Ib), aromatic steroids (II), Δ 16(11) -steroids (Illa and I…

USPTO Abstract

Disclosed are Δ 9(11) -steroids (VI) and amino substituted steroids of formula (XI) which contain an amino group attached to the terminal carbon atom of the C 17 -side chain, more particularly amino steroids (la and Ib), aromatic steroids (II), Δ 16(11) -steroids (Illa and IIIb), reduced A-ring steroids (IV), Δ 17(20) -steroids (Va and Vb) and Δ 9(11) -steroids (VI) which are useful as pharmaceutical agents for treating a number of conditions.

Drugs covered by this patent

Patent Metadata

Patent number
EP0263213A1
Jurisdiction
EP
Classification
—
Expires
1988-04-13
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacia and Upjohn Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.